Coaching for HCV and HIV

Boston Medical Center (BMC)

Status: Completed

Conditions: Opioid-use Disorder; Hepatitis C; HIV Infections

Treatments: Other: PRC brief motivational interview intervention; Other: Phone contact

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT04314414

H-39712

1UL1TR001430 (U.S. NIH Grant/Contract)

5P30AI042853 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The objective of this study is to determine the feasibility and acceptability of a peer recovery coach (PRC) intervention to improve linkage to hepatitis C (HCV) and/or human immunodeficiency virus (HIV) care, treatment initiation, and evaluation for HIV pre-exposure prophylaxis (PrEP) (when applicable) among individuals with a history of opioid use disorder accessing a substance use low-barrier-to-access (LBA) walk-in clinic.

In-depth interviews will be administered to participants at baseline, three- and six-months for study participants (40 total participants). The investigator will also follow-up with the per recovery coach and administer surveys to assess the feasibility of a peer recovery coaching intervention in improving HCV/HIV related linkage to care and management. Patient medical records and peer recovery coach monthly reports will be accessed and reviewed to determine fidelity to research protocols.

Full description

*NOTE* Due to the COVID-19 pandemic, surveys were conducted via telephone and not all participants could be contacted. Therefore, the number of results from participants at three months and six months vary. The data gathered are from participants that were reachable and completed the surveys.

Enrollment: 31 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Individuals with opioid use disorder, non-reactive HIV antibody test and reactive HCV antibody testing at the BMC LBA walk-in clinic
• Able to speak English
• Individuals providing contact information of two family members or friends
• Individuals signing a medical records release form

Exclusion criteria

• Individuals already linked to substance use care
• Individuals co-infected with HIV and HCV and engaged in care

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

31 participants in 1 patient group

Intervention group

Experimental group

Description:

Participants in the intervention group will receive a semi-scripted brief motivational interview from the peer recovery coach (PRC) in addition to the standard of care at Boston Medical Center (BMC) for HIV, HCV, and opioid use disorder.

Treatment:

Other: Phone contact

Other: PRC brief motivational interview intervention